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0bjectives: Purpose of this study was to compare CT Based Volumetric calculation and 
ICRU Reference points estimates of Radiation doses to bladder & rectum in patients with 
Carcinoma of Cervix treated with HDR Intracavitary Brachytherapy. 
Material and Methods: 30 Carcinoma Cervix patients were treated with HDR 
Brachytherapy underwent post implant CT–scans.The EBRT dose was 50Gy in 
25fractions.HDR Brachytherapy delivered to dose of 21Gy in 3fractions .ICRU 
rectal&bladder doses along with 4 additional rectal points were recorded.By using HDR 
Brachytherapy planning system bladder & rectum were contoured on the CT datasets. 
The DVHs for rectum & bladder were calculated and the minimum doses to highest 
irradiated 2cc area of rectum & bladder were recorded(D2cc) for all individual 
fractions.The mean rectal dose compared to means of ICRU rectal point and rectal Dmax 
using students t–test.The mean 2cc of bladder compared with mean ICRU bladder 
point.The total dose combining EBRT & HDR Brachytherapy were biologically 
normalized to conventional 2Gy/fraction using Linear Quadratic model(α/β value of 
10Gy for target & 3Gy for organs at risk). 
Results:  The total prescribed dose was 82.12Gy α/β 10.The mean dose to rectum was 
4.48±1.22Gy for D2cc,3.66±0.65 at ICRU.The mean rectal D2cc dose differed 
significantly from mean dose calculated at ICRU reference point(p0.005).The mean dose 
to bladder was 6.00±1.90Gy for D2cc & 5.00±2.03 at ICRU.However bladder D2cc dose 
did not differ significantly from mean dose calculated at ICRU reference point(p=0.307). 
Conclusion : OARs doses assessed by DVH were higher than ICRU point doses.Our data 
suggest that ICRU bladder point may be reasonable target for D2cc.However dose to 
ICRU rectal point doesn’t appear reasonable target for D2cc. 
